GHTM

Global Health and Tropical Medicine

  • GHTM
    • About GHTM
    • Governance
    • Impact
    • Members
    • Scientific Advisory Board
    • Reports
      • GHTM
  • Research
    • Cross-cutting issues
      • Antimicrobial Resistance and Drug Discovery
      • Host–Pathogen Interactions
      • Genomic Surveillance and Population Mobility
      • Implementation and Translational Research
      • Information for Health Development
      • Fair Research Partnerships
    • Research Groups
      • PPS – Population health, policies and services
      • PRIME – Pathogen resistance, infection and molecular epidemiology
      • VBD – Vector borne diseases
      • CTM – Clinical tropical medicine
    • Research in numbers
      • 2023
      • 2022
      • 2021
      • 2020
      • 2019
      • 2018
      • 2017
    • Projects
      • Ongoing Projects
      • Completed Projects
  • Outreach
    • Events
    • News
    • Policy Support & Community Outreach
  • Publications
    • 2024
    • 2023
    • 2022
    • 2021
    • 2020
    • 2019
    • 2018
    • 2017
    • 2016
    • 2015
  • Capacity Building
    • Education
      • Master Theses
      • PhD Theses
    • International
  • Infrastructures
    • BIOHUB & Available Software
    • BIOTROP Biobank
    • VIASEF & Insectaries
  • Networks & Partnerships
Home / Events / GHTM Sessions | Finding a needle in a haystack: How BAR-seq screens identified the critical role of the Leishmania V-ATPase

GHTM Sessions | Finding a needle in a haystack: How BAR-seq screens identified the critical role of the Leishmania V-ATPase

February 23, 2026

📅 Date: 11 March 2026
🕒 Time: 14:00-16:00
📍 Location: ZOOM & SALA FRAGA DE AZEVEDO

Leishmania parasites must adjust their physiology and nutrient acquisition to thrive in two very different hosts: the phlebotomine sand fly and the mammalian macrophage. Transporter proteins, which mediate the movement of solutes, ions, metabolites, and drugs across membranes, play a central role in this adaptation.

To uncover which transporters are critical for parasite viability and fitness, CRISPR/Cas9 was used to construct a library of over 300 barcoded deletion mutants targeting the complete set of solute transporters, ion pumps, and channels in L. mexicana. Approximately two-thirds of genes could be deleted without preventing growth of cultured promastigotes, while one-third appeared refractory to deletion, under these conditions. A minority of the viable mutants displayed dramatic reduction of growth rates in vitro.

When tested in more physiological environments – human iPSC-derived macrophages, mice, and sand flies – many additional mutants exhibited pronounced fitness defects. These included several mitochondrial transporters and proton pumps. Notably, the vacuolar H⁺ ATPase (V-ATPase) was dispensable for promastigote proliferation in axenic culture but proved essential for parasite survival inside macrophages, within mice, and in the sand fly gut.

Together, these findings highlight how parasite requirements differ between artificial culture and natural hosts. They emphasize the V-ATPase as a central regulator of homeostasis under in vivo conditions and identify a set of transporters that are essential for amastigote survival and therefore represent promising candidates for further functional investigation.

 

About Andreia Albuquerque Wendt

Andreia Wendt completed her PhD in 2018 at the Medical School of Hannover, Germany, focusing on the glycobiology of Apicomplexan parasites. She then joined Prof. Eva Gluenz’s lab in the UK and Switzerland, where she used CRISPR/Cas9 and BAR-seq approaches to characterize the transportome of Leishmania across its life cycle. This work revealed that the vacuolar proton ATPase pump is essential for parasite survival in both mammalian and vector hosts. Andreia Wendt is currently a project leader in a collaborative effort between Swiss Tropical and Public Health Institute, Allschwil, Switzerland (Swiss TPH), and Charles University, Czech Republic, developing novel transmission-blocking strategies against Leishmania. Her research explores the complex interactions between host, pathogen, and vector, aiming to inform innovative approaches for controlling and ultimately eradicating leishmaniases.

If you are a GHTM member, you will receive the details of the session by e-mail. If you are not a GHTM member and would like to join the session, please contact us at ghtm-info@ihmt.unl.pt.

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • Share on LinkedIn (Opens in new window) LinkedIn
  • Share on Pinterest (Opens in new window) Pinterest
  • Share on WhatsApp (Opens in new window) WhatsApp
  • Print (Opens in new window) Print

About GHTM

GHTM is a R&D Unit that brings together researchers with a track record in Tropical Medicine and International & Global Health. It aims at strengthening Portugal's role as a leading partner in the development and implementation of a global health research agenda. Our evidence-based interventions contribute to the promotion of equity in health and to improve the health of populations.

Contacts

Rua da Junqueira, 100
1349-008 Lisboa
Portugal

+351 213 652 600

  • Email
  • Facebook
  • LinkedIn
  • Twitter
  • YouTube

Funding

UID/04413/2025 - DOI: 10.54499/UID/04413/2025

UID/PRR/04413/2025 - DOI: 10.54499/UID/PRR/04413/2025

UID/PRR2/04413/2025 - DOI: 10.54499/UID/PRR2/04413/2025

  • Events
  • Research Groups
  • Cross-cutting issues
© Copyright 2026 IHMT-UNL All Rights Reserved.
  • Universidade Nova de Lisboa
  • Fundação para a Ciência e a Tecnologia

    UIDB/04413/2020
    UIDP/04413/2020

Loading Comments...

    We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.